Chemoinformaics analysis of Undeca-1,3,5-triene
| Molecular Weight | 150.265 | nRot | 6 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 3 |
| Exact Molecular Weight | 150.141 | nRing | 0 |
| Solubility: LogS | -3.218 | nHRing | 0 |
| Solubility: LogP | 3.528 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 30.3723 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.398 |
| Synth | 2.76 |
| Natural Product Likeliness | 2.391 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.473 |
| MDCK | 0.0000201 |
| BBB | 0.951 |
| PPB | 0.841262 |
| VDSS | 0.995 |
| FU | 0.156776 |
| CYP1A2-inh | 0.866 |
| CYP1A2-sub | 0.749 |
| CYP2c19-inh | 0.624 |
| CYP2c19-sub | 0.893 |
| CYP2c9-inh | 0.241 |
| CYP2c9-sub | 0.98 |
| CYP2d6-inh | 0.888 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.227 |
| CYP3a4-sub | 0.184 |
| CL | 3.414 |
| T12 | 0.24 |
| hERG | 0.02 |
| Ames | 0.443 |
| ROA | 0.047 |
| SkinSen | 0.95 |
| Carcinogencity | 0.642 |
| EI | 0.993 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.853454 |